Neurosurgery, Neuro-Oncology
-
People
-
Professorships
- Ali-Osman, Francis, Margaret Harris and David Silverman Professor Emeritus of Neuro-Oncology Research
- Friedman, Henry Seth, James B. Powell, Jr. Distinguished Professor of Pediatric Oncology, in the School of Medicine
-
Primary Appointments
- Adams, Shawn William, Clinical Associate in the Department of Neurosurgery
- Ali-Osman, Francis, Professor Emeritus in Neurosurgery
- Brown, Michael, Assistant Professor in Neurosurgery
- Chandramohan, Vidyalakshmi, Associate Professor in Neurosurgery
- Desjardins, Annick, Professor of Neurosurgery
- Friedman, Henry Seth, Professor of Neurosurgery
- Gromeier, Matthias, Professor of Neurosurgery
- Keir, Stephen Thomas, Professor in Neurosurgery
- Ostrom, Quinn, Assistant Professor in Neurosurgery
- Peters, Katherine Barnett, Associate Professor of Neurosurgery
-
-
Administers Grant
- 6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
- A Phase 1/2 Trial for Patients with Newly Diagnosed High Grade Glioma Treated with Concurrent Radiation Therapy, Temozolomide, and BMX-001
- ATRX Mutations in Determining Immunity Against Glioma
- ATRXmutations,innate immune activation and therapeutic vunerabilityin malignant gliomas
- Anti-tumor efficacy of EGFR-targeting immunotoxin in combination with CCNU or PD-L1 blockade in glioma mouse models
- Antiglioma efficacy of intratumoral D2C7-IT+human-CD40 and Lymph Node Human-CD40 Combination in hCD40/hFcyR Transgenic Mice
- Assessment of ST101 in Glioblastoma
- Cell Type-Specific Viral Translation in the CNS
- Central Brain Tumor Registry of the United States (CBTRUS) Statistical Analysis
- Cis and Trans-acting Factors in HCV Gene Expression
- Clinical development of novel blood-based biomarkers for glioma targeted immunotoxin therapy
- Enterovirus Vectors with Respiratory Tropism for Cancer Immunotherapy
- Evaluation of Cannabinoid Therapeutics in Brain Tumor Xenografts
- Evaluation of Panobinostat in Patient Derived Adult IDH1 Mutated Brain Tumor Xenografts
- Immunotoxin and chemotherapy/PD-L1 combinations for glioblastoma
- Intrathecal Busulfan Therapy of Neoplastic Meningitis
- Is Low Tumor Mutational Burden Predictive of Response to Oncolytic Polio Virus Therapy in Recurrent Glioblastoma?
- Myeloid and Lymphoid markers for D2C7-IT therapy in glioblastomas
- NUTMEG Tissue Analysis
- Oncolytic Viral Therapy in Brain Tumor Setting
- Oncolytic Virotherapy of Meningeal Cancer
- Oncolytic poliovirus therapy of malignant glioma
- PRECLINICAL THERAPEUTIC SCREENING FOR NEW THERAPIES FOR GLIOBLASTOMA MULTIFORME
- Ph 1/2 Trial for Patients with Newly Diagnosed High Grade Glioma Treated with Concurrent Radiation Therapy, Temozolomide, and BMX-001
- Pharmacologic Prevention of Arteriovenous Graft Thrombosis
- Phase I open label ascending dose study to assess the feasibility and safety of intermittent infusions of MTX110 administered by convection-enhanced delivery (CED) as a monotherapy or in combination with lomustine in patients with recurrent glioblast
- Phase II Study of 44Gy from 131I-81C6 for CNS Tumors
- Regional AGT Depletion of CNS and Leptomeningeal Tumors
- Research Training In Neuro-Oncology
- Research Training In Neuro-Oncology
- Synergestic microglial activation and tumor cell killing for improved GBM response
- Synthetic lethal strategies for targeting ATRX deficiency and the Alternative Lengthening of Telomeres in Pediatric High-Grade Gliomas
- Targeting Brain Tumor Stem Cells
- Targeting Translation Control in Malignant Glioma
- Temodar Resistance in CNS Tumors
- The role of SMARCAL1 in glioma telomere maintenance.
- Therapies for Glioblastoma Multiforme
- Therapies for Glioblastoma Multiforme
- Transgenic Mouse Model for the Common Cold
- Understanding the Mechanism of Type-I/III Interferon Dominant Inflammation Induced by PVSRIPO Immunotherapy